Page last updated: 2024-10-24

epidermal growth factor receptor ligand maturation

Definition

Target type: biologicalprocess

Any process leading to the attainment of the full functional capacity of a ligand for an epidermal growth factor receptor. The ligand is functional when it can bind to and activate an epidermal growth factor receptor. [GOC:signaling, PMID:11672524, PMID:11672525]

Epidermal growth factor receptor (EGFR) ligand maturation is a complex process that involves the synthesis, processing, and activation of a family of polypeptide growth factors that bind to and activate EGFR. These ligands include epidermal growth factor (EGF), transforming growth factor alpha (TGFα), amphiregulin, heparin-binding EGF-like growth factor (HB-EGF), and epiregulin.

The process begins with the synthesis of the precursor proteins for each ligand as transmembrane proteins. These precursors are typically synthesized with a signal peptide, a transmembrane domain, and an extracellular domain that contains the mature ligand sequence.

**Proteolytic Processing:** The maturation of EGFR ligands involves proteolytic cleavage of the precursor protein, releasing the mature ligand from the cell surface. This cleavage can be mediated by a variety of proteases, including metalloproteases, furin, and ADAM (a disintegrin and metalloproteinase) family members. The specific protease involved in the cleavage of each ligand can vary depending on the cell type and the specific context.

**Activation:** Once cleaved from the cell surface, the mature EGFR ligands can bind to and activate EGFR. The binding of the ligand to EGFR triggers a cascade of intracellular signaling events that ultimately lead to cell growth, proliferation, and survival.

**Regulation of Ligand Maturation:** The maturation of EGFR ligands is tightly regulated. This regulation is important for ensuring that the ligands are only produced and activated when needed, and that their activity is appropriately controlled.

**Factors that can influence ligand maturation include:**

* **Cell type:** Different cell types express different levels of EGFR ligands and proteases, which can affect the rate of ligand maturation.
* **Growth factors and cytokines:** Certain growth factors and cytokines can induce the expression of EGFR ligands or their processing enzymes.
* **Cellular stress:** Stress conditions, such as hypoxia or DNA damage, can also influence the maturation of EGFR ligands.
* **Post-translational modifications:** The maturation of EGFR ligands can be further regulated by post-translational modifications, such as glycosylation and phosphorylation.

**In summary, the maturation of EGFR ligands is a complex process involving multiple steps, including synthesis, processing, and activation. The regulation of this process is critical for controlling EGFR signaling and maintaining cellular homeostasis.**'
"

Proteins (1)

ProteinDefinitionTaxonomy
Disintegrin and metalloproteinase domain-containing protein 10A disintegrin and metalloproteinase domain-containing protein 10 that is encoded in the genome of human. [PRO:WCB, UniProtKB:O14672]Homo sapiens (human)

Compounds (4)

CompoundDefinitionClassesRoles
ilomastatCS 610: matrix metalloproteinase inhibitor; structure in first source

ilomastat : An N-acyl-amino acid obtained by formal condensation of the carboxy group of (2R)-2-[2-(hydroxyamino)-2-oxoethyl]-4-methylpentanoic acid with the amino group of N-methyl-L-tryptophanamide. A cell permeable broad-spectrum matrix metalloproteinase (MMP) inhibitor
hydroxamic acid;
L-tryptophan derivative;
N-acyl-amino acid
anti-inflammatory agent;
antibacterial agent;
antineoplastic agent;
EC 3.4.24.24 (gelatinase A) inhibitor;
neuroprotective agent
bms-566394BMS-566394: structure in first source
incb3619INCB3619: ADAM inhibitor; structure in first source
grassystatin agrassystatin A: isolated from a cyanobacterium, identified as Lyngbya cf.; structure in first source